Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (7299)	8/17/1998 2:47:00 PM
From: musicguy	Read Replies (2) \| Respond to of 25711

NUKE news: VANCOUVER, British Columbia--(BUSINESS WIRE)--Aug. 17, 1998--Rhombic Corporation (OTC BB:NUKE), a U.S. OTC Bulletin Board company, announces that Daimler Benz Aerospace (DASA), is now providing colored pictures, descriptions, and technical information on the Inertial Electrostatic (IEC) point source-1 neutron generator through its internet Web site, www.dasa.com/fusionstar. Rhombic also notes that DASA has begun a worldwide marketing effort for the first IEC neutron generators to be produced at the Trauen plant in Germany. MG

To: Joe Copia who wrote (7299)	8/17/1998 9:56:00 PM
From: LaShark	Read Replies (1) \| Respond to of 25711

AGISS News, AGCR Joe, I posted this company as a possible play last week. I should have some solid DD material by Friday. AGISS Forms Software Company, Biochemical Computing Incorporated PR Newswire - August 17, 1998 15:49 OTTAWA, Aug. 17 /PRNewswire/ -- AGISS Corporation (OTC Bulletin Board: AGCR) announces today the formation of Biochemical Computing Incorporated, a wholly owned subsidiary of AGISS Corporation. Biochemical Computing is a software research and development company, focusing on a product that analyzes the toxicological hazards of drugs or chemicals on living organisms. "Biochemical Computing is an exciting venture for AGISS Corporation," said Robert Sowah, CEO. "The software developed by Biochemical Computing, which is being tested today at beta sites, will substantially cut the time-to-market for drug and chemical companies by reducing the amount of testing required. The software will also reduce the amount of animal testing required by drug and cosmetic companies." "Drug and chemical testing is a multi-billion dollar industry," says Anicet Blais, President, "and as one of AGISS Corporations core competencies, the Biochemical Computing software is hoping to carve out a niche for itself." AGISS Software Corporation is a leading provider of automated conversion tools and services to solve the Year 2000 conversion across many different platforms. Its Canadian methodology for correcting the Millennium problem is called REMEDY2000(TM) and is marketed worldwide. AGISS Software focuses on Year 2000 conversion, Euro Conversion, software development and system integration. The following is a "safe harbor" statement under the private Securities Litigation Reform Act of 1995: "This release may contain forward-looking statements that involve risks and uncertainties which might cause the actual results to differ materially from those projected in any forward-looking statements. Factors, which could affect actual results include the development and introduction of competitive technologies, the overall market demand for conversion services, the presence of technologically-inferior products and services which are priced or promoted to compete with AGISS." SOURCE AGISS Corporation /CONTACT: Thomas M. Dean or Michael Block, both of Murdock Capital Partners Corp., 212-421-2545, for AGISS Corporation/ (AGCR)